Company Monitoring Page for Alkermes

latest headlines for company on cafepharma

Thu, 10/27/16 - 03:23 pm
Tags:
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
24/7 Wall St
Sat, 10/22/16 - 03:30 pm
Tags:
Alkermes, depression, suicide, suicidal ideation, ALKS 5461
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
Forbes
Thu, 10/20/16 - 08:13 pm
Tags:
biotech, FDA, Alkermes, clinical depression, ALKS 5461, antidepressants
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
Tue, 08/23/16 - 10:00 am
Tags:
GSK, Merck, Valeant Pharmaceuticals, Endo International, Sagent Pharmaceuticals, Alkermes, Shire, Perrigo
FDA Prevails in Otsuka Challenge to Scope of ABILIFY 3-Year Exclusivity, Leaving Intact ARISTADA 505(b)(2) NDA Approval
FDA Law Blog
Mon, 08/1/16 - 09:36 am
Tags:
FDA, Otsuka, Abilify, exclusivity, Aristada, Alkermes
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Forbes
Tue, 02/9/16 - 09:28 am
Tags:
Alkermes, Richard Pops, ALKS 5461, clinical depression
Alkermes slammed as top depression drug fails two PhIIIs
Fierce Biotech
Thu, 01/21/16 - 05:42 pm
Tags:
Alkermes, ALKS-5461, clinical depression, clinical trials
Alkermes’s Aristada Demonstrates High Efficacy as Schizophrenia Therapy
Yahoo/Market Realist
Mon, 10/12/15 - 04:31 pm
Tags:
Alkermes, Aristada, schizophrenia
Alkermes wins an FDA nod for its monthly schizophrenia drug
Fierce Biotech
Tue, 10/6/15 - 09:58 am
Tags:
FDA, Alkermes, schizophrenia, Aristada, Abilify
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
Tags:
FDA, Exelixis, vemurafenib, aripiprazole lauroxil, Alkermes, evolocumab, Amgen, Bristol-Myers Squibb, Opdivo, Clovis Oncology, rociletinib
Alkermes heads to Phase III with a schizophrenia drug designed to spare the waistline
Fierce Biotech
Mon, 04/6/15 - 11:45 am
Tags:
Alkermes, schizophrenia, ALKS 3831
Alkermes shares down after it stops development of pain pill
Bizjournals.com
Tue, 02/24/15 - 02:16 pm
Tags:
Alkermes, painkillers, ALKS 7106
Alkermes says its more tolerable Tecfidera rival is ready for pivotal challenge
Fierce Biotech
Mon, 02/9/15 - 05:59 pm
Tags:
Alkermes, ALKS 8700, MS, multiple sclerosis, Biogen Idec, Tecfidera
Alkermes sees PhII promise for schizophrenia drug that doesn't pack on pounds
Fierce Biotech
Wed, 01/7/15 - 09:21 am
Tags:
Alkermes, schizophrenia, ALKS 3831
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y
Yahoo/Zacks
Sat, 11/1/14 - 12:46 pm
Tags:
Alkermes, earnings
3 Likely Biotech Buyout Candidates
24/7 Wall St
Mon, 09/29/14 - 09:27 am
Tags:
biotech, M&A, Alkermes, Jazz Pharmaceuticals, Salix
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Yahoo/Zacks.com
Fri, 09/5/14 - 07:57 am
Tags:
Alkermes, ALKS 3831, schizophrenia
Alkermes closer to launching once-monthly schizophrenia drug into a crowded market
Fierce Biotech
Tue, 08/26/14 - 10:36 pm
Tags:
Alkermes, Abilify Maintena, schizophrenia
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tue, 07/22/14 - 08:54 am
Tags:
Alkermes, Invega Sustenna, ALKS 3831, aripiprazole lauroxil, ALKS 5461
Alkermes takes its Tecfidera beater into clinical trials for MS
Fierce Biotech
Thu, 07/17/14 - 10:01 am
Tags:
Alkermes, Tecfidera, MS, multiple sclerosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.